{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T01:37:42Z","timestamp":1780969062001,"version":"3.54.1"},"reference-count":10,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2013,4,1]],"date-time":"2013-04-01T00:00:00Z","timestamp":1364774400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,4,1]],"date-time":"2013-04-01T00:00:00Z","timestamp":1364774400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacionline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Allergy and Clinical Immunology"],"published-print":{"date-parts":[[2013,4]]},"DOI":"10.1016\/j.jaci.2012.09.034","type":"journal-article","created":{"date-parts":[[2012,11,13]],"date-time":"2012-11-13T04:34:21Z","timestamp":1352781261000},"page":"1235-1237.e1","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["Induction of severe systemic lupus erythematosus by TNF blockade and response to anti\u2013IL-6 strategy"],"prefix":"10.1016","volume":"131","author":[{"given":"Sabine","family":"Adler","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mirjam","family":"Kolev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre-Alain","family":"Varisco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuela","family":"Tham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"von Gunten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoph","family":"Tappeiner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter M.","family":"Villiger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaci.2012.09.034_bib1","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1136\/ard.2007.083675","article-title":"The effectiveness and medication costs of three anti-tumour necrosis factor alpha agents in the treatment of rheumatoid arthritis from prospective clinical practice data","volume":"67","author":"Kievit","year":"2008","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jaci.2012.09.034_bib2","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1136\/ard.2008.105197","article-title":"Comparison of tocilizumab monotherapy versus methotrexate monotherapy in patients with moderate to severe rheumatoid arthritis: the AMBITION study","volume":"69","author":"Jones","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jaci.2012.09.034_bib3","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1002\/ajim.4700280505","article-title":"Silica exposure and autoimmune diseases","volume":"28","author":"Steenland","year":"1995","journal-title":"Am J Ind Med"},{"key":"10.1016\/j.jaci.2012.09.034_bib4","doi-asserted-by":"crossref","first-page":"1840","DOI":"10.1002\/art.10368","article-title":"Occupational exposure to crystalline silica and risk of systemic lupus erythematosus: a population-based, case-control study in the Southeastern United States","volume":"46","author":"Parks","year":"2002","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jaci.2012.09.034_bib5","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1136\/ard.2007.083584","article-title":"Infliximab efficacy and safety against refractory systemic necrotising vasculitides: long-term follow-up of 15 patients","volume":"67","author":"Josselin","year":"2008","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jaci.2012.09.034_bib6","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.autrev.2007.03.009","article-title":"Potential target of infliximab in autoimmune and inflammatory diseases","volume":"6","author":"Atzeni","year":"2007","journal-title":"Autoimm Rev"},{"key":"10.1016\/j.jaci.2012.09.034_bib7","first-page":"432595","article-title":"Inflammatory cytokines in systemic lupus erythematosus","volume":"2011","author":"Ohl","year":"2011","journal-title":"J Biomed Biotech"},{"key":"10.1016\/j.jaci.2012.09.034_bib8","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1016\/j.autrev.2010.07.009","article-title":"Microscopic polyangiitis: clinical presentation","volume":"9","author":"Villiger","year":"2010","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.jaci.2012.09.034_bib9","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1093\/rheumatology\/kep080","article-title":"Anti-TNF-induced lupus","volume":"48","author":"Williams","year":"2009","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.jaci.2012.09.034_bib10","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1002\/art.27221","article-title":"Tocilizumab in systemic lupus erythematosus: data on safety, preliminary efficacy, and impact on circulating plasma cells from an open-label phase I dosage-escalation study","volume":"62","author":"Illei","year":"2010","journal-title":"Arthritis Rheum"}],"container-title":["Journal of Allergy and Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674912016132?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674912016132?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T08:40:37Z","timestamp":1758789637000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0091674912016132"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,4]]},"references-count":10,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2013,4]]}},"alternative-id":["S0091674912016132"],"URL":"https:\/\/doi.org\/10.1016\/j.jaci.2012.09.034","relation":{},"ISSN":["0091-6749"],"issn-type":[{"value":"0091-6749","type":"print"}],"subject":[],"published":{"date-parts":[[2013,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Induction of severe systemic lupus erythematosus by TNF blockade and response to anti\u2013IL-6 strategy","name":"articletitle","label":"Article Title"},{"value":"Journal of Allergy and Clinical Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaci.2012.09.034","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 American Academy of Allergy, Asthma & Immunology. Published by Mosby, Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}